Itraconazole in onychomycosis: Intermittent dose schedule

International Journal of Dermatology

Volumn 36, Issue 1, 1997, Pages 70-72

  Bonifaz, Alexandro ^a,b   Carrasco Gerard, Eugenio ^a   Saúl, Amado ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ADULT; AGED; ARTICLE; CANDIDA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FINGER NAIL; GASTROINTESTINAL DISEASE; HUMAN; LIVER DYSFUNCTION; MALE; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; TOE; TRICHOPHYTON;

EID: 0030891724     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00025.x     Document Type: Article

References (9)

1. Zaias N, Drachman D. A method for the determination of drug effectiveness in onychomycosis. J Am Acad Dermatol 1983; 9: 912-919.
2. Hay RJ, Clayton YM, Moore MK, et al. An evaluation of itraconazole in the management of onychomycosis. Br J Dermatol 1988; 119: 359-366.
3. Gupta AK, Sauder D, Shear NH. Antifungal agents: an overview. Part II. J Am Acad Dermatol 1994; 30: 911-933.
4. Willemsen M, De Doncker P, Willems J, et al. Posttreatment itraconazole levels in the nail. J Am Acad Dermatol 1992; 26: 731-735.
5. Roseeuw D, De Doncker P. New approaches to the treatment of onychomycosis. J Am Acad Dermatol 1993; 29: 115-117.
6. Hay RJ, Baran R, Moore MK, et al. Candida onychomycosis. An evaluation of the role of Candida species in nail disease. Br J Dermatol 1988; 118: 47-58.
7. Dhondt A, Cauwenbergh G, De Doncker P. Short oral therapy in difficult-to-treat tinea infections. J Eur Acad Dermatol Venereol 1992; 1 (Suppl.): S11-14.
8. Van Peer A, Woestenborghs R, Heykants J, et al. The effects of the food and dose on the oral systemic availability of itraconazole in healthy subjects. Eur J Clin Pharmacol 1989; 36: 423-426.
9. Lim SG. The absorption of fluconazole and itraconazole under low acid conditions. XII Congress ISHAM, Adelaide, March 13-18 1994, abstract S11-4: 13.